• Мавлянова Ш.З., Шукуров И.Б., Яхшиева М.Ф.
  1 - Республиканский специализированный научно – практический медицинский центр дерматове-нерологии и косметологии, Республика Узбекистан, г. Ташкент; 2 - Бухарский государственный медицинский институт, Республика Узбекистан, г. Бухара

---

Abstract

Витилиго является самым распространенным в дерматологии гипомеланозом, классифицируется как аутоиммунное генетически опосредованное заболевание, связанное с факторами окружающей среды, метаболическим и окислительным стрессом, активностью иммунной системы и аномалиями строения клеток. Статья носит обзорный характер, в ней освещены современные данные о патогенезе витилиго.

Keywords

витилиго, окислительный стресс, Т клетки памяти, врожденный иммунитет, адаптивный иммунитет, регуляторные Т клетки.

Literature

Alikhan A, Felsten LM, Daly M, Petronic Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011 Sep;65(3):473–91.

Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16(3):208–214

Arifov S.S., Shukurov I.B NO-ergic system in vitiligo Pathology No. 2 2009. pp. 20-23.

Arifov S.S., Shukurov I.B. Some aspects of the clinical course of vitiligo according to the Bukhara Regional CVD. Problems of dermatovenerology Ukraine Harkov 2009. pp. 301-302.

Arifov S.S., Shukurov I.B. Some medical and social aspects of vitiligo. Ukrainian Journal of Dermatovenerology and Cosmetology No. 1(40) 2011.

Bergqvist C, Ezzedine K. Vitiligo: A Review Dermatology. 2020;236(6):571-592. doi: 10.1159/000506103. Epub 2020 Mar 10.

Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 2006 Dec;126(12):2565–75

Boldyrev A.A. Oxidative stress and the brain. Sorovsky Educational magazine. 2001; 4: 21-8

Boniface K, et al. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clin Rev Allergy Immunol. 2018; 54:52–67.

Cui T, Zhang W, Li S, et al. Oxidative stress-induced HMGB1 release from melanocytes: a paracrine mechanism underlying the cutaneous inflammation in vitiligo. J Invest Dermatol. 2019;139(10):2174–2184. e.

Dwivedi M, et al. Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics. Autoimmun Rev. 2015 Jan;14(1):49–56.

Eby JM, et al. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. J Invest Dermatol. 2015 Jun;135(6):1574–80

Frączek A, Owczarczyk-Saczonek A, Placek W. The role of TRM cells in the pathogenesis of vitiligo-a review of the current state-of-the-art. Int J Mol Sci. 2020; 21:3552.

Gill L, et al. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. J Am Acad Dermatol. 2016;74(2):295–302

Hamidizadeh N, et al. Evaluating prevalence of depression, anxiety and hopelessness in patients with vitiligo on an Iranian population. Health Qual Life Outcomes. 2020; 18:20.

Harris JE, et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J Invest Dermatol. 2012;132(7):1869–1876

Harris JE. Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo. Immunol Rev. 2016 Jan;269(1):11–25.

Ismailov R.G. Etiopathogenetic aspects of vitiligo in modern interpretation // Bulletin of problems of biology and medicine. 2012. pp. 14-17.

Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44(6):676–680

Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/ adolescents and adults. Int J Dermatol. 2012 Oct;51(10):1206–12.

Kruglova L.S. Vitiligo: modern views on etiology, pathogenesis and methods of therapy. Russian Journal of Skin and Venereal Diseases. 2016; 19(4): 241-244. DOI: 10.18821/1560-9588-2016-19-4-241-244

Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017; 177:708–718.

Lin M, Zhang BX, Shen N, Dong XJ, Zhang C, Qi XY, et al. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells. Eur J Dermatol. 2014 Nov-Dec;24(6):676–82

Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol. 1997 Sep;109(3):310–3.

Mavlyanova Sh. Z., Shukurov I. B., Yahshiyeva M. F. //Assessment of the Dermatological Index of the Symptom Scale in Patients with Seborrheic Dermatitis and Opportunistic Infection Based On the Use of Natural Silicon Oxide //Annals of R.S.C.B., Vol. 25, Issue 4, 2021, Pages. 3922 – 3930 Received 05 March 2021; Accepted 01 April 2021.

Mosenson JA, et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Science translational medicine. 2013;5(174):174ra28

Picardo M, et al. Vitiligo. Nat Rev Dis Primers. 2015 Jun;1(1):15011

Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. 2014 Feb;6(223): 223ra23.

Richmond JM, et al. Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease. J Invest Dermatol. 2017 Feb; 137(2):350–8.

Richmond JM, Masterjohn E, Chu R, Tedstone J, Youd ME, Harris JE. CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice. J Invest Dermatol. 2017 Apr;137(4):982–5.

Sabirov U.Yu., Azimova F.V., Toirov B.A., Muminova S.R., Nazarova I.I. The Wnt signaling pathway and its significance in the development of vitiligo. // Medical News Magazine. Minsk, 2019. - No. 12. - S. 22-26. (14.00.00; №82)

Shen C, Gao J, Sheng Y, Dou J, Zhou F, Zheng X, et al. Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci. Front Genet. 2016; 7:3.

Shukurov I.B., Yakhshieva M.F., The study of the prevalence and medical and social aspects of vitiligo in the Bukhara region Universum: medicine and pharmacology.Moscow 2021.P. 8-13.

Singh RK, et al. The role of IL-17 in vitiligo: a review. Autoimmun Rev. 2016; 15:397–404

Speeckaert R, et al. Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2018 Jul; 32(7):1089–98

Spritz R.A. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol. 2012;132(2):268–273.

Toosi S, et al. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol. 2012;132(11):2601–2609

Van den Boorn JG, et al. Inflammasome-Dependent Induction of Adaptive NK Cell Memory. Immunity. 2016;44(6):1406–1421.

Wagner RY, et al. Altered ECadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol. 2015 Jul;135(7): 1810–9.

Wang X, et al. Increased Expression of CXCR3 and its Ligands in Vitiligo Patients and CXCL10 as a Potential Clinical Marker for Vitiligo. Br J Dermatol. 2016

Wu S, et al.  Use of permanent hair dyes and risk of vitiligo in women. Pigment Cell Melanoma Res. 2015;28(6):744–746.

Yang L. et al. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo. Acta Derm Venereol. 2015 Jul;95(6):664–70

Yu R, Broady R, Huang Y, Wang Y, Yu J, Gao M, et al. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS One. 2012;7(12): e51040.

Yusupova L.A., Yunusova E. I., Garaeva Z. Sh., Mavlyutova G. I. Modern approaches to external therapy of patients with vitiligo // Practical medicine. 2014. No. 8 (84). pp. 24-26.